Overview
- A class action was filed in the U.S. District Court for the Northern District of California and covers buyers of PROCEPT stock from February 28, 2024 through February 25, 2026 with a September 22, 2026 deadline to seek lead-plaintiff status.
- Plaintiffs allege PROCEPT ran an extensive discount program that induced customers to place bulk handpiece orders beyond actual procedure demand, artificially inflating reported U.S. handpiece unit sales and revenue.
- The company disclosed that handpiece unit sales exceeded performed procedures every quarter since the first quarter of 2023, producing what it described as more than 10,000 excess handpieces in the field by the end of the class period.
- Disclosures about shipments, inventory management and procedure data produced sharp stock drops after August 6, 2025, November 4, 2025, and February 25, 2026 and underlie investors’ alleged losses.
- Multiple plaintiff firms are actively soliciting investors to move for lead-plaintiff appointment and the case could prompt closer scrutiny of PROCEPT’s SEC filings, recurring-revenue metrics, and how medical-device companies report customer inventory trends.